Federal Agency to Cease Collection of Adverse Drug Reports
The Consumer Product Safety Commission will stop collecting data on injuries from adverse drug effects and other incidents like car accidents, according to a report from Reuters.
Tag: pharmaceuticals
All
Latest
Federal Agency to Cease Collection of Adverse Drug Reports
The Consumer Product Safety Commission will stop collecting data on injuries from adverse drug effects and other incidents like car accidents, according to a report from Reuters.
Read More
Frequent Pediatric Antibiotics May Increase Asthma, Allergy Risks
Repeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Read More
Novel COVID Antiviral May Overcome Paxlovid Limitations
In laboratory testing, new drug candidate Jun13296 remained effective against Paxlovid-resistant strains of the coronavirus SARS-CoV-2.
Read More
Low-sugar Vaccine Provides Broad Immunity Against Coronavirus Variants
Researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Read More
Current Antivirals Less Effective Against Severe Bird Flu
Two FDA–approved flu antivirals did not successfully treat severe H5N1 infections, and route of infection (eye, nose or mouth) significantly impacted effectiveness.
Read More
Statins, Aspirin and Chest Muscle Loss in Smokers
A study of current and former smokers reveals positive and negative effects of common medications like statins and aspirin on chest muscle loss.
Read More
Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read More
United States Measles Cases Reach 712
The CDC says a total of 712 confirmed measles cases have been reported by 24 states, driven by outbreaks in Texas, New Mexico, Kansas and now Ohio.
Read More
FDA Issues Recommendations for Flu Vaccine Composition
The FDA convened an interagency panel to comprise its recommendations for the 2025-2026 flu vaccine composition.
Read More
Inhaled COVID Vaccine Begins Recruitment for Phase 2 Trial
The phase 2 The AeroVax study will evaluate the safety and effectiveness of a novel inhaled COVID-19 vaccine.
Read More
Actionable Strategies to Address Patient Healthcare Access, Affordability and Adherence
Approximately 20% of patients surveyed modified their prescriptions because they could not afford their medications or left the pharmacy without their prescription once they learned the prescription would cost more than expected.
Read More
Tezspire Significantly Reduced Nasal Congestion, Polyp Size in CRwNP Patients
Tezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.
Read More
Study Compares Xolair to Oral Immunotherapy in Treating Food Allergies
Xolair was superior to oral immunotherapy in both effectiveness and fewer side effects for people with one or more food allergies.
Read More
Researchers Question Paxlovid’s Impact on COVID-19 Outcomes
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to UCLA-led research.
Read More
Acetaminophen Overdoses Reported in Flu Patients
Cold and flu season is the time of year when Poison Control Centers see an increase in calls related to the overuse of acetaminophen to alleviate flu-like symptoms.
Read More
FDA Approves New Class of Non-Opioid Pain Medication
The FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, according to the agency.
Read More
UK’s NICE Recognizes Cytisine as Key Smoking Cessation Treatment
The 2025 NICE update includes Cytisine as a recommended smoking cessation treatment after its UK launch and a review of clinical evidence.
Read More
Three New Ways To Treat Drug-Resistant Tuberculosis
An international clinical trial has found three new safe and effective drug regimens for tuberculosis that is resistant to rifampin, the most effective of the first-line antibiotics used to treat TB.
Read More
Why a Common Asthma Drug Will Now Carry Extra Safety Warnings About Depression
Australia’s Therapeutic Goods Administration recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.
Read More
Experimental Vaccine Protects Mice Against Bird Flu Circulating in Cattle
The RNA-based vaccine showed full protection in mice against the H5N1 strain circulating in US cattle.
Read More
FDA: Label Similarities Between Epinephrine Products Causing Dangerous Confusion
Similarities in bottle and packaging labels between unapproved nasal and FDA-approved injectable epinephrine products make it difficult to distinguish them, risking accidental injections of the nasal solution.
Read More
COPD Patients Face Higher Fall Risk When Taking Common Medications
Nearly one-third of COPD patients prescribed fall-risk medications experienced injuries in the two years before death.
Read More
Study Identifies Best Smoking Cessation Approach for Patients Undergoing Lung Cancer Screening
The study compared three smoking cessation approaches for lung cancer screening patients and found one outperformed the other methods by nearly two-fold.
Read More
Priority Review Granted for Drug Targeting Advanced EGFR-Mutated NSCLC
The treatment, designed for patients with advanced EGFR-mutated NSCLC resistant to prior therapies, could offer a new option pending FDA approval.
Read More